Price T Rowe Associates Inc Amgen Inc Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,137,491 shares of AMGN stock, worth $960 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,137,491

Previous 6,564,710 52.21%

Holding current value

$960 Million

Previous $1.89 Billion 52.82%

% of portfolio

0.11%

Previous 0.25%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $921 Million - $1.11 Billion	-3,427,219 Reduced 52.21%	3,137,491 $892 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $62.3 Million - $70.3 Million	243,720 Added 3.86%	6,564,710 $1.89 Billion
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $324 Million - $402 Million	1,480,001 Added 30.57%	6,320,990 $1.7 Billion
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $218 Million - $258 Million	1,018,577 Added 26.65%	4,840,989 $1.07 Billion
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $197 Million - $240 Million	872,399 Added 29.57%	3,822,412 $924 Million

Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $414 Million - $526 Million	1,806,456 Added 157.97%	2,950,013 $775 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $164 Million - $185 Million	-730,736 Reduced 38.99%	1,143,557 $258 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $182 Million - $202 Million	-788,648 Reduced 29.62%	1,874,293 $456 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1.23 Million - $1.36 Million	-5,595 Reduced 0.21%	2,662,941 $644 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $9.38 Million - $10.7 Million	47,146 Added 1.8%	2,668,536 $600 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $21.2 Million - $24.9 Million	-99,938 Reduced 3.67%	2,621,390 $557 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $31.5 Million - $35 Million	-135,011 Reduced 4.73%	2,721,328 $663 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $45.3 Million - $52.8 Million	-204,010 Reduced 6.67%	2,856,339 $711 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $662 Million - $789 Million	3,060,349 New	3,060,349 $704 Million

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Amgen Inc Transaction History